Advanced non-small cell lung cancer in elderly patients: The standard every 3-weeks versus weekly paclitaxel with carboplatin

Background: Paclitaxel and platinum-based chemotherapy is considered to be a standard approach for locally advanced and metastatic non-small cell lung cancer (NSCLC). In recent years, paclitaxel on a weekly schedule in combination with carboplatin has been widely used because it is associated with a...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Hala Mohamed El-Shenshawy, Saleh Taema, Eman El-Zahaf, Wafaa El-Beshbeshi, Doaa Sharaf Eldeen, Amal Fathy
Médium: Artigo
Jazyk:Inglês
Vydáno: Wolters Kluwer Medknow Publications 2012-10-01
Edice:Egyptian Journal of Chest Disease and Tuberculosis
Témata:
Elderly
Non-small cell lung cancer
Paclitaxel
Carboplatin
On-line přístup:http://www.sciencedirect.com/science/article/pii/S0422763812000763
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky